Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2003
12/31/2003WO2004001378A2 Methods for protein analyses and protein expression in multicellular organisms and cells therefrom
12/31/2003WO2004001376A2 Apparatus for polynucleotide detection and quantitation
12/31/2003WO2004001371A2 Receptor capture assay
12/31/2003WO2004001074A1 Method for detecting foreign dna in a host genome
12/31/2003WO2004001073A1 Method and kit for the diagnosis of ulcerative colitis
12/31/2003WO2004001072A2 Method for diagnosis of colorectal tumors
12/31/2003WO2004001071A2 Genetic predisposition analysis and treatment
12/31/2003WO2004001070A1 Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis
12/31/2003WO2004001069A2 Compositions and methods for detecting pathologies affecting neuromuscular transmission
12/31/2003WO2004001068A2 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/31/2003WO2004001067A2 Detection of toxic algae
12/31/2003WO2004001066A1 Method of screening malt and process for producing foaming malt beverage
12/31/2003WO2004001065A2 Exhaustive selection or rna aptamers against complex targets
12/31/2003WO2004001063A2 Methods and compositions for monitoring primer extension and polymorphism detection reactions
12/31/2003WO2004001062A2 Multiplex nucleic acid reactions
12/31/2003WO2004001047A1 Novel promoter
12/31/2003WO2004001044A1 Randomised dna libraries and double-stranded rna libraries, use and method of production thereof
12/31/2003WO2004001042A2 Microarrays displaying encoded molecules
12/31/2003WO2004001037A1 Method of diagnosing risk of myocardial infarction
12/31/2003WO2004001016A2 Methods for detection of genetic alterations associated with cancer
12/31/2003WO2004001015A2 Method for sequencing nucleic acids
12/31/2003WO2004001014A2 Osteopontin, oligodendrocytes and myelination
12/31/2003WO2004001010A2 METHODS FOR IDENTIFYING SMALL MOLECULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY
12/31/2003WO2004001006A2 Hepatic gene expression profiling of streptozotocin-induced diabetes
12/31/2003WO2004001004A2 Membrane associated tumor endothelium markers
12/31/2003WO2004000999A2 Identification of a receptor controlling migration and metastasis of skin cancer cells
12/31/2003WO2004000998A2 Compositions and methods for viral resistance genes
12/31/2003WO2004000997A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/31/2003WO2004000996A2 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation
12/31/2003WO2004000995A2 Methods, probes, and accessory molecules for detecting single nucleotide polymorphisms
12/31/2003WO2004000875A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
12/31/2003WO2004000867A1 Diagnostic phenotype assay for engineered cells and tissues
12/31/2003WO2004000367A1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
12/31/2003WO2004000328A1 Biosynthesis of hif
12/31/2003WO2004000229A2 Treatment of human multiple myeloma by curcumin
12/31/2003WO2004000228A2 Methods for preventing and treating microbial infections by modulating transcription factors
12/31/2003WO2004000220A2 Methods for purifying viral particles for gene therapy
12/31/2003WO2004000102A2 Method for predicting response to epidermal growth factor receptor-directed therapy
12/31/2003WO2004000096A2 Novel bartonella antigen lysate extracts for use in elisa diagnostic
12/31/2003WO2004000009A2 Methods for selection for efficient animal growth
12/31/2003WO2003087774A3 Ecist microarrays for dual screening of dna hypermethylation and gene silencing
12/31/2003WO2003087336A3 Estrogen receptor alpha regulated gene expression, related assays and therapeutics
12/31/2003WO2003087315A3 Pre-and post therapy gene expression profiling to identify drug targets
12/31/2003WO2003085129A8 Detection of mycobacteria in clinical material
12/31/2003WO2003080869A3 Storing and detecting nucleic acid administered to a solid carrier
12/31/2003WO2003078582A3 Integrated system for high throughput capture of genetic diversity
12/31/2003WO2003076659A3 Facl4 and mutation thereof on x-linkend mental retardation syndrome
12/31/2003WO2003076658A3 A susceptibility gene for late-onset idiopathic parkinson's disease
12/31/2003WO2003074733A3 Improvements in and relating to marking
12/31/2003WO2003072817A3 Increasing the sensitivity and specificity of nucleic acid chip hybridization tests
12/31/2003WO2003070980A3 Nucleic acid quantification
12/31/2003WO2003070876A3 Method for attaching nucleic acid molecules to electrically conductive surfaces
12/31/2003WO2003069421A3 Methods and algorithms for cell enumeration in a low-cost cytometer
12/31/2003WO2003069309A3 Immunocapture and functional assay for mitochondrial complex i
12/31/2003WO2003068981A3 Method for reducing background contamination after marking reactions
12/31/2003WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia
12/31/2003WO2003066901A3 Nucleic acid analysis using type is restriction endonucleases
12/31/2003WO2003066884A3 Method for labeling articles
12/31/2003WO2003065795A3 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
12/31/2003WO2003064471A3 Gene for peripheral arterial occlusive disease
12/31/2003WO2003064465A3 Prkag3 gene promoter and uses thereof
12/31/2003WO2003062376A3 Molecules for diagnostics and therapeutics
12/31/2003WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
12/31/2003WO2003061453A3 Device and method for the identification of analytes in bodily fluids
12/31/2003WO2003060077A3 Endothelial stem cells, populations, methods of isolation and use thereof
12/31/2003WO2003057858A3 Nucleic acid hybridization-based biosensing devices and methods utilizing intelligently-designed oligonucleotide probe sets
12/31/2003WO2003056036A3 Genes
12/31/2003WO2003056034A3 Method for the in vitro selection of binders
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003052138A3 Methods of detecting modification of genetic material
12/31/2003WO2003048310A3 Thermus oshimai nucleic acid polymerases
12/31/2003WO2003047606A3 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors
12/31/2003WO2003040408A3 Detection of predisposition to osteoporosis
12/31/2003WO2003038399A3 Chemiluminescent acridinium compounds and their use in an assay to detect analytes
12/31/2003WO2003033734A3 Diagnostic tests for the diagnosis of copper storage disease
12/31/2003WO2003031965A3 Microfluidic extraction method
12/31/2003WO2003025174A3 Regulation of human mrp1-like protein
12/31/2003WO2003023353A3 Particle based homogeneous assays using capillary electrophoresis with laser-induced fluorescence detection
12/31/2003WO2003023035A3 Glucosyltransferases which glucosylate abscisic acid
12/31/2003WO2003020968A3 Method for analyzing nucleic acid sequences and gene expression
12/31/2003WO2003016566A3 Improvements relating to capillary gel array analysis
12/31/2003WO2003016527A3 Process for the detection of oxidative stress and kit for its implementation
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2003001985A3 Method for detection of melanoma
12/31/2003WO2003001181A9 Detection of clonal t-cell receptor-gamma gene rearrangement by pcr/temporal temperature gradient gel electrophoresis (tige)
12/31/2003WO2002097059B1 Chromosome-based platforms
12/31/2003WO2002095000A8 Molecular toxicology modeling
12/31/2003WO2002092774A3 Replicase cycling reaction amplification
12/31/2003WO2002083944A3 Chemical compounds for identification of slc10a2 gene polymorphisms
12/31/2003WO2002071070A3 β-ADRENOCEPTOR GENETIC POLYMORPHISMS AND OBESITY
12/31/2003WO2002070740A3 Test system for determining gene toxicities
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002066984A3 Arrays for determining binding of biomolecules
12/31/2003WO2002064796A3 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use
12/31/2003WO2002059136A8 Immunoglobulin class switch recombination
12/31/2003WO2002057469A3 Modulating developmental transitions in plants
12/31/2003WO2002044714A8 System and method for integrated analysis of data for characterizing carbohydrate polymers
12/31/2003WO2002042775A3 Clinically intelligent diagnostic devices and methods
12/31/2003WO2002042444A3 Fungal gene cluster associated with pathogenesis
12/31/2003WO2002040718A3 Method to identify genes associated with chronic myelogenous leukemia
1 ... 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 ... 3003